Redefining Thyroid Hormone Sensitivity in Diabetic Kidney Disease: A Paradigm Shift in Pathophysiological Understanding [Letter]

Abstract

Yanni Gao,1 Zhenliang Fan2 1The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People’s Republic of China; 2The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, People’s Republic of ChinaCorrespondence: Zhenliang Fan, Email [email protected]

Keywords

• BOLD MRI
• Sacubitril/valsartan
• Diabetic kidney disease
• Natriuretic peptide Introduction